Veeva Systems

Boehringer Ingelheim now has a single source of truth for clinical trials. Michael Haushalter, Senior Principal Capability Manager, shares how a unified platform facilitates collaboration between data management and clinical operations to deliver treatments faster. Watch the full story to see how they transformed their clinical development process: https://lnkd.in/gDPHXk-3 #ClinicalTrials #DigitalTransformation #LifeSciences

Bad clinical reference data can delay site startup and operations by weeks, leading to lost productivity and added trial costs. With clean data, clinical leaders can achieve: - Consistent, verified data at scale - Real-time, automated data maintenance - Operational efficiency and staff focus - A reliable data foundation for AI Learn more: https://lnkd.in/g2t5-gkP

In a recent article in ComputerWeekly.com, Bernard Seiser of AOP Health shares a clear view of what digital transformation needs to deliver in life sciences: fewer silos, stronger foundations, and end-to-end processes that help teams work with greater speed, transparency, and control. That is what makes this story so interesting. AOP Health is taking a connected approach across clinical, development, quality, and commercial, with a clear focus on building the right backbone first and creating room for better data, analytics, and AI over time. As Bernard says, the goal is to create a way of working where there are “no handovers, no breaks in the process,” with the same level of transparency and security throughout. A strong example of how digital leaders are helping shape the future of life sciences. https://lnkd.in/d3yKXVan

Architecting the AI-ready enterprise isn't about deploying technology everywhere at once, it's about pinpointing the exact value-generating processes where AI can deliver the biggest step change in performance. In the first episode of #WhatPharmaNeedsNext, Kieron Scrutton of GSK shares their story of identifying the essential building blocks required to scale AI safely and efficiently, and why keeping a human in the loop remains a top priority. Listen to the full podcast: https://lnkd.in/dTVjuEZE Spotify: https://lnkd.in/gyyAiW_D YouTube: https://lnkd.in/g8JVDPVD Apple Podcasts: https://lnkd.in/gC6ZsT3d #LifeSciences #VeevaAI

Boehringer Ingelheim has established a new global standard for data-driven trials. By implementing a unified clinical data strategy, they eliminated 40+ systems and established a one-stop shop for data management. This transformation has delivered: ✅ Six-figure cost savings ✅ 100+ hours saved via automation ✅ Faster database locks Join us on April 22 to see the technology behind this shift and learn how to automate cleaning and risk-based review using AI: https://lnkd.in/gPhFdnbn

eSource is pivotal, yet challenging to scale. Nick Frenzer details why it is time to rethink eSource and the roles of research sites, sponsors, and IT in Applied Clinical Trials. https://lnkd.in/g9BR2nbn #ClinicalTrials #eSource #ACRP2026

Fortrea has now successfully deployed VeevaID to more than 4,500 site users. This isn't just about a new login; it’s about respect for our site partners' time. By removing the need for redundant training and multiple credentials, we’re simplifying the clinical trial ecosystem so researchers can prioritize patient care over paperwork. Explore the full case study: https://lnkd.in/g9K43Ty2 #ClinicalInnovation #Fortrea #LifeSciences

Michelle Marlborough explains how designing a new eCOA model in partnership with data managers can standardize eCOA across studies. Learn how this approach improves study outcomes in PharmaLive. https://lnkd.in/g4EyHYs9 #eCOA #ClinicalTrials

Orchestras rehearse before performances, firefighters drill before deployments, and pilots train before flights. Yet, we often ask sites to run their first full visit when a real patient is already sitting in the room. Keenova is partnering with Veeva to make clinical trial rehearsals the gold standard for site readiness. By providing sandbox EDC environments, sites move beyond static training to hands-on mastery. This enables them to master the tech in a zero-risk environment and identify workflow bottlenecks before the first patient walks through the door. This isn't just about better data. It’s about respect for the site's time and the patient’s experience. To deliver faster treatments, we must equip sites to succeed from the start. Learn more: https://lnkd.in/gK-hEaVc

As we move through 2026, the broad "do everything" model is shifting to operational discipline and strategic focus. In this piece, I share strategies for CDMOs to proactively adapt their operations today to lead the industry tomorrow, including: • Quality as a Sales Driver: To counter the trend of insourcing, CDMOs must provide real-time transparency and data integrity that matches a sponsor’s internal standards. • The CIO-CQO Alliance: Success in complex modalities, like ADCs and cell therapy, requires total alignment between IT and Quality. From retiring technical debt to deploying Agentic AI, this partnership is key to scale. • Geography as a Quality Attribute: Legislation, like the BIOSECURE Act, has made location a competitive differentiator. Sponsors are now prioritizing partners based on regional access and supply chain security. Read the full article in Contract Pharma here: https://lnkd.in/eGYGZa66  #CDMO #Biopharma #Quality #BIOSECUREAct #DigitalTransformation